AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

BEMIPARINE

15 registrations across 1 African market— 15 active

Markets with BEMIPARINE

Recent registrations

Brand / ProductMarketHolderStatusExpires
HIBOR 5000 UI ANTI XA
SOLUTION INJECTABLE
🇲🇦Moroccoactive
HIBOR 10000 UI ANTI XA
SOLUTION INJECTABLE
🇲🇦Moroccoactive
HIBOR 3500 UI ANTI XA
SOLUTION INJECTABLE
🇲🇦Moroccoactive
HIBOR 3500 UI ANTI XA
SOLUTION INJECTABLE
🇲🇦Moroccoactive
HIBOR 2500 UI ANTI XA
SOLUTION INJECTABLE
🇲🇦Moroccoactive
HIBOR 5000 UI ANTI XA
SOLUTION INJECTABLE
🇲🇦Moroccoactive
HIBOR 2500 UI ANTI XA
SOLUTION INJECTABLE
🇲🇦Moroccoactive
HIBOR 7500 UI ANTI XA
SOLUTION INJECTABLE
🇲🇦Moroccoactive
HIBOR 10000 UI ANTI XA
SOLUTION INJECTABLE
🇲🇦Moroccoactive
HIBOR 7500 UI ANTI XA
SOLUTION INJECTABLE
🇲🇦Moroccoactive
HIBOR 5000 UI ANTI XA
SOLUTION INJECTABLE
🇲🇦Moroccoactive
HIBOR 2500 UI ANTI XA
SOLUTION INJECTABLE
🇲🇦Moroccoactive
HIBOR 3500 UI ANTI XA
SOLUTION INJECTABLE
🇲🇦Moroccoactive
HIBOR 7500 UI ANTI XA
SOLUTION INJECTABLE
🇲🇦Moroccoactive
HIBOR 10000 UI ANTI XA
SOLUTION INJECTABLE
🇲🇦Moroccoactive

BEMIPARINE in Africa — Regulatory Overview

BEMIPARINE is registered across 1 African markets with 15 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Morocco. AfricaRegulatory refreshes this data daily from official government sources.

Of the 15 registrations, 15 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.